{"entity":{"type":"insider","cik":"0001305240","url":"/insider/0001305240","json_url":"/insider/0001305240.json","name":"Venrock Partners Management, LLC","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":24,"n_filings":13,"first":"2006-10-25","last":"2019-10-28","span_basis":"filed_date"},"name_variants":[{"name":"Venrock Partners Management, LLC","source":"filing","n_filings":13,"first_seen":"2006-10-25","last_seen":"2019-10-28"}],"transactions":[{"id":8419432,"accession":"0001209191-19-054264","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001209191-19-054264","line_url":"/filing/0001209191-19-054264#line-3","is_derivative":false,"issuer_cik":"0001277994","issuer_name":"Bellerophon Therapeutics, Inc.","issuer_ticker":"BLPH","issuer_name_source":null,"issuer_url":"/issuer/0001277994","owner_cik":null,"owner_name":"VENROCK ASSOCIATES IV L P; Venrock Management IV, LLC; Venrock Healthcare Capital Partners II, L.P.; VHCP Management II, LLC; VHCP Co-Investment Holdings II, LLC; Koh Bong Y; VENROCK ENTREPRENEURS FUND IV L P; Venrock Partners, L.P.; Venrock Partners Management, LLC; VEF Management IV, LLC","owner_display_name":"VENROCK ASSOCIATES IV L P","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":10,"other_reporting_owners":9,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":333010.0,"shares_display":"333,010","price_per_share":0.4387,"price_display":"0.44","price_state":"stated","total_value":146091.487,"total_display":"146,091.49","total_whole":"146,091","shares_owned_after":6435173.0,"shares_owned_after_display":"6,435,173","ownership_form":"I","is_10b5_1":null,"transaction_date":"2019-10-28","filed_date":"2019-10-28","scope":"insider"},{"id":8419428,"accession":"0001209191-19-054264","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-19-054264","line_url":"/filing/0001209191-19-054264#line-2","is_derivative":false,"issuer_cik":"0001277994","issuer_name":"Bellerophon Therapeutics, Inc.","issuer_ticker":"BLPH","issuer_name_source":null,"issuer_url":"/issuer/0001277994","owner_cik":null,"owner_name":"VENROCK ASSOCIATES IV L P; Venrock Management IV, LLC; Venrock Healthcare Capital Partners II, L.P.; VHCP Management II, LLC; VHCP Co-Investment Holdings II, LLC; Koh Bong Y; VENROCK ENTREPRENEURS FUND IV L P; Venrock Partners, L.P.; Venrock Partners Management, LLC; VEF Management IV, LLC","owner_display_name":"VENROCK ASSOCIATES IV L P","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":10,"other_reporting_owners":9,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":56242.0,"shares_display":"56,242","price_per_share":0.4536,"price_display":"0.45","price_state":"stated","total_value":25511.3712,"total_display":"25,511.37","total_whole":"25,511","shares_owned_after":6768183.0,"shares_owned_after_display":"6,768,183","ownership_form":"I","is_10b5_1":null,"transaction_date":"2019-10-25","filed_date":"2019-10-28","scope":"insider"},{"id":8419422,"accession":"0001209191-19-054264","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-19-054264","line_url":"/filing/0001209191-19-054264#line-1","is_derivative":false,"issuer_cik":"0001277994","issuer_name":"Bellerophon Therapeutics, Inc.","issuer_ticker":"BLPH","issuer_name_source":null,"issuer_url":"/issuer/0001277994","owner_cik":null,"owner_name":"VENROCK ASSOCIATES IV L P; Venrock Management IV, LLC; Venrock Healthcare Capital Partners II, L.P.; VHCP Management II, LLC; VHCP Co-Investment Holdings II, LLC; Koh Bong Y; VENROCK ENTREPRENEURS FUND IV L P; Venrock Partners, L.P.; Venrock Partners Management, LLC; VEF Management IV, LLC","owner_display_name":"VENROCK ASSOCIATES IV L P","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":10,"other_reporting_owners":9,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":704595.0,"shares_display":"704,595","price_per_share":0.5015,"price_display":"0.50","price_state":"stated","total_value":353354.3925,"total_display":"353,354.39","total_whole":"353,354","shares_owned_after":6824425.0,"shares_owned_after_display":"6,824,425","ownership_form":"I","is_10b5_1":null,"transaction_date":"2019-10-24","filed_date":"2019-10-28","scope":"insider"},{"id":7801238,"accession":"0001209191-19-019526","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-19-019526","line_url":"/filing/0001209191-19-019526#line-1","is_derivative":false,"issuer_cik":"0001277994","issuer_name":"Bellerophon Therapeutics, Inc.","issuer_ticker":"BLPH","issuer_name_source":null,"issuer_url":"/issuer/0001277994","owner_cik":null,"owner_name":"VHCP Co-Investment Holdings II, LLC; VENROCK ENTREPRENEURS FUND IV L P; Venrock Partners, L.P.; Venrock Healthcare Capital Partners II, L.P.; Koh Bong Y; Venrock Management IV, LLC; VHCP Management II, LLC; VENROCK ASSOCIATES IV L P; Venrock Partners Management, LLC; VEF Management IV, LLC","owner_display_name":"VHCP Co-Investment Holdings II, LLC","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":10,"other_reporting_owners":9,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":142857.0,"shares_display":"142,857","price_per_share":0.7,"price_display":"0.70","price_state":"stated","total_value":99999.9,"total_display":"99,999.90","total_whole":"100,000","shares_owned_after":7529020.0,"shares_owned_after_display":"7,529,020","ownership_form":"I","is_10b5_1":null,"transaction_date":"2019-01-23","filed_date":"2019-03-14","scope":"insider"},{"id":6608812,"accession":"0001209191-18-051215","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001209191-18-051215","line_url":"/filing/0001209191-18-051215#line-3","is_derivative":false,"issuer_cik":"0001277994","issuer_name":"Bellerophon Therapeutics, Inc.","issuer_ticker":"BLPH","issuer_name_source":null,"issuer_url":"/issuer/0001277994","owner_cik":null,"owner_name":"Venrock Partners, L.P.; VENROCK ENTREPRENEURS FUND IV L P; VHCP Co-Investment Holdings II, LLC; Venrock Management IV, LLC; Koh Bong Y; VHCP Management II, LLC; Venrock Healthcare Capital Partners II, L.P.; VEF Management IV, LLC; VENROCK ASSOCIATES IV L P; Venrock Partners Management, LLC","owner_display_name":"Venrock Partners, L.P.","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":10,"other_reporting_owners":9,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":60000.0,"shares_display":"60,000","price_per_share":1.1824,"price_display":"1.18","price_state":"stated","total_value":70944.0,"total_display":"70,944.00","total_whole":"70,944","shares_owned_after":7386163.0,"shares_owned_after_display":"7,386,163","ownership_form":"I","is_10b5_1":null,"transaction_date":"2018-09-17","filed_date":"2018-09-17","scope":"insider"},{"id":6608810,"accession":"0001209191-18-051215","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-18-051215","line_url":"/filing/0001209191-18-051215#line-2","is_derivative":false,"issuer_cik":"0001277994","issuer_name":"Bellerophon Therapeutics, Inc.","issuer_ticker":"BLPH","issuer_name_source":null,"issuer_url":"/issuer/0001277994","owner_cik":null,"owner_name":"Venrock Partners, L.P.; VENROCK ENTREPRENEURS FUND IV L P; VHCP Co-Investment Holdings II, LLC; Venrock Management IV, LLC; Koh Bong Y; VHCP Management II, LLC; Venrock Healthcare Capital Partners II, L.P.; VEF Management IV, LLC; VENROCK ASSOCIATES IV L P; Venrock Partners Management, LLC","owner_display_name":"Venrock Partners, L.P.","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":10,"other_reporting_owners":9,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":75000.0,"shares_display":"75,000","price_per_share":1.23,"price_display":"1.23","price_state":"stated","total_value":92250.0,"total_display":"92,250.00","total_whole":"92,250","shares_owned_after":7326163.0,"shares_owned_after_display":"7,326,163","ownership_form":"I","is_10b5_1":null,"transaction_date":"2018-09-14","filed_date":"2018-09-17","scope":"insider"},{"id":6608807,"accession":"0001209191-18-051215","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-18-051215","line_url":"/filing/0001209191-18-051215#line-1","is_derivative":false,"issuer_cik":"0001277994","issuer_name":"Bellerophon Therapeutics, Inc.","issuer_ticker":"BLPH","issuer_name_source":null,"issuer_url":"/issuer/0001277994","owner_cik":null,"owner_name":"Venrock Partners, L.P.; VENROCK ENTREPRENEURS FUND IV L P; VHCP Co-Investment Holdings II, LLC; Venrock Management IV, LLC; Koh Bong Y; VHCP Management II, LLC; Venrock Healthcare Capital Partners II, L.P.; VEF Management IV, LLC; VENROCK ASSOCIATES IV L P; Venrock Partners Management, LLC","owner_display_name":"Venrock Partners, L.P.","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":10,"other_reporting_owners":9,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":75000.0,"shares_display":"75,000","price_per_share":1.1888,"price_display":"1.19","price_state":"stated","total_value":89160.0,"total_display":"89,160.00","total_whole":"89,160","shares_owned_after":7251163.0,"shares_owned_after_display":"7,251,163","ownership_form":"I","is_10b5_1":null,"transaction_date":"2018-09-13","filed_date":"2018-09-17","scope":"insider"},{"id":6021097,"accession":"0001209191-18-050736","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001209191-18-050736","line_url":"/filing/0001209191-18-050736#line-3","is_derivative":false,"issuer_cik":"0001277994","issuer_name":"Bellerophon Therapeutics, Inc.","issuer_ticker":"BLPH","issuer_name_source":null,"issuer_url":"/issuer/0001277994","owner_cik":null,"owner_name":"Koh Bong Y; Venrock Healthcare Capital Partners II, L.P.; Venrock Partners Management, LLC; VENROCK ENTREPRENEURS FUND IV L P; VHCP Management II, LLC; Venrock Partners, L.P.; VHCP Co-Investment Holdings II, LLC; Venrock Management IV, LLC; VEF Management IV, LLC; VENROCK ASSOCIATES IV L P","owner_display_name":"Koh Bong Y","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":10,"other_reporting_owners":9,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":75000.0,"shares_display":"75,000","price_per_share":1.1455,"price_display":"1.15","price_state":"stated","total_value":85912.5,"total_display":"85,912.50","total_whole":"85,913","shares_owned_after":7176163.0,"shares_owned_after_display":"7,176,163","ownership_form":"I","is_10b5_1":null,"transaction_date":"2018-09-12","filed_date":"2018-09-12","scope":"insider"},{"id":6021093,"accession":"0001209191-18-050736","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-18-050736","line_url":"/filing/0001209191-18-050736#line-2","is_derivative":false,"issuer_cik":"0001277994","issuer_name":"Bellerophon Therapeutics, Inc.","issuer_ticker":"BLPH","issuer_name_source":null,"issuer_url":"/issuer/0001277994","owner_cik":null,"owner_name":"Koh Bong Y; Venrock Healthcare Capital Partners II, L.P.; Venrock Partners Management, LLC; VENROCK ENTREPRENEURS FUND IV L P; VHCP Management II, LLC; Venrock Partners, L.P.; VHCP Co-Investment Holdings II, LLC; Venrock Management IV, LLC; VEF Management IV, LLC; VENROCK ASSOCIATES IV L P","owner_display_name":"Koh Bong Y","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":10,"other_reporting_owners":9,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":200000.0,"shares_display":"200,000","price_per_share":1.1442,"price_display":"1.14","price_state":"stated","total_value":228840.0,"total_display":"228,840.00","total_whole":"228,840","shares_owned_after":7101163.0,"shares_owned_after_display":"7,101,163","ownership_form":"I","is_10b5_1":null,"transaction_date":"2018-09-11","filed_date":"2018-09-12","scope":"insider"},{"id":6021082,"accession":"0001209191-18-050736","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-18-050736","line_url":"/filing/0001209191-18-050736#line-1","is_derivative":false,"issuer_cik":"0001277994","issuer_name":"Bellerophon Therapeutics, Inc.","issuer_ticker":"BLPH","issuer_name_source":null,"issuer_url":"/issuer/0001277994","owner_cik":null,"owner_name":"Koh Bong Y; Venrock Healthcare Capital Partners II, L.P.; Venrock Partners Management, LLC; VENROCK ENTREPRENEURS FUND IV L P; VHCP Management II, LLC; Venrock Partners, L.P.; VHCP Co-Investment Holdings II, LLC; Venrock Management IV, LLC; VEF Management IV, LLC; VENROCK ASSOCIATES IV L P","owner_display_name":"Koh Bong Y","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":10,"other_reporting_owners":9,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":200000.0,"shares_display":"200,000","price_per_share":1.2182,"price_display":"1.22","price_state":"stated","total_value":243640.0,"total_display":"243,640.00","total_whole":"243,640","shares_owned_after":6901163.0,"shares_owned_after_display":"6,901,163","ownership_form":"I","is_10b5_1":null,"transaction_date":"2018-09-10","filed_date":"2018-09-12","scope":"insider"},{"id":6765303,"accession":"0001209191-18-050122","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001209191-18-050122","line_url":"/filing/0001209191-18-050122#line-3","is_derivative":false,"issuer_cik":"0001277994","issuer_name":"Bellerophon Therapeutics, Inc.","issuer_ticker":"BLPH","issuer_name_source":null,"issuer_url":"/issuer/0001277994","owner_cik":null,"owner_name":"Venrock Partners, L.P.; VHCP Co-Investment Holdings II, LLC; VHCP Management II, LLC; VENROCK ENTREPRENEURS FUND IV L P; VENROCK ASSOCIATES IV L P; Venrock Management IV, LLC; VEF Management IV, LLC; Venrock Partners Management, LLC; Koh Bong Y; Venrock Healthcare Capital Partners II, L.P.","owner_display_name":"Venrock Partners, L.P.","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":10,"other_reporting_owners":9,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":60000.0,"shares_display":"60,000","price_per_share":0.8957,"price_display":"0.90","price_state":"stated","total_value":53742.0,"total_display":"53,742.00","total_whole":"53,742","shares_owned_after":6701163.0,"shares_owned_after_display":"6,701,163","ownership_form":"I","is_10b5_1":null,"transaction_date":"2018-09-07","filed_date":"2018-09-07","scope":"insider"},{"id":6765299,"accession":"0001209191-18-050122","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-18-050122","line_url":"/filing/0001209191-18-050122#line-2","is_derivative":false,"issuer_cik":"0001277994","issuer_name":"Bellerophon Therapeutics, Inc.","issuer_ticker":"BLPH","issuer_name_source":null,"issuer_url":"/issuer/0001277994","owner_cik":null,"owner_name":"Venrock Partners, L.P.; VHCP Co-Investment Holdings II, LLC; VHCP Management II, LLC; VENROCK ENTREPRENEURS FUND IV L P; VENROCK ASSOCIATES IV L P; Venrock Management IV, LLC; VEF Management IV, LLC; Venrock Partners Management, LLC; Koh Bong Y; Venrock Healthcare Capital Partners II, L.P.","owner_display_name":"Venrock Partners, L.P.","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":10,"other_reporting_owners":9,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":50000.0,"shares_display":"50,000","price_per_share":0.8419,"price_display":"0.84","price_state":"stated","total_value":42095.0,"total_display":"42,095.00","total_whole":"42,095","shares_owned_after":6641163.0,"shares_owned_after_display":"6,641,163","ownership_form":"I","is_10b5_1":null,"transaction_date":"2018-09-06","filed_date":"2018-09-07","scope":"insider"},{"id":6765297,"accession":"0001209191-18-050122","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-18-050122","line_url":"/filing/0001209191-18-050122#line-1","is_derivative":false,"issuer_cik":"0001277994","issuer_name":"Bellerophon Therapeutics, Inc.","issuer_ticker":"BLPH","issuer_name_source":null,"issuer_url":"/issuer/0001277994","owner_cik":null,"owner_name":"Venrock Partners, L.P.; VHCP Co-Investment Holdings II, LLC; VHCP Management II, LLC; VENROCK ENTREPRENEURS FUND IV L P; VENROCK ASSOCIATES IV L P; Venrock Management IV, LLC; VEF Management IV, LLC; Venrock Partners Management, LLC; Koh Bong Y; Venrock Healthcare Capital Partners II, L.P.","owner_display_name":"Venrock Partners, L.P.","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":10,"other_reporting_owners":9,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":50000.0,"shares_display":"50,000","price_per_share":0.8465,"price_display":"0.85","price_state":"stated","total_value":42325.0,"total_display":"42,325.00","total_whole":"42,325","shares_owned_after":6591163.0,"shares_owned_after_display":"6,591,163","ownership_form":"I","is_10b5_1":null,"transaction_date":"2018-09-05","filed_date":"2018-09-07","scope":"insider"},{"id":6523517,"accession":"0001209191-18-047212","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001209191-18-047212","line_url":"/filing/0001209191-18-047212#line-3","is_derivative":false,"issuer_cik":"0001277994","issuer_name":"Bellerophon Therapeutics, Inc.","issuer_ticker":"BLPH","issuer_name_source":null,"issuer_url":"/issuer/0001277994","owner_cik":null,"owner_name":"VHCP Management II, LLC; VEF Management IV, LLC; VHCP Co-Investment Holdings II, LLC; Venrock Healthcare Capital Partners II, L.P.; Venrock Partners Management, LLC; Koh Bong Y; VENROCK ENTREPRENEURS FUND IV L P; Venrock Partners, L.P.; VENROCK ASSOCIATES IV L P; Venrock Management IV, LLC","owner_display_name":"VHCP Management II, LLC","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":10,"other_reporting_owners":9,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":66393.0,"shares_display":"66,393","price_per_share":0.6493,"price_display":"0.65","price_state":"stated","total_value":43108.9749,"total_display":"43,108.97","total_whole":"43,109","shares_owned_after":6541163.0,"shares_owned_after_display":"6,541,163","ownership_form":"I","is_10b5_1":null,"transaction_date":"2018-08-16","filed_date":"2018-08-16","scope":"insider"},{"id":6523514,"accession":"0001209191-18-047212","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-18-047212","line_url":"/filing/0001209191-18-047212#line-2","is_derivative":false,"issuer_cik":"0001277994","issuer_name":"Bellerophon Therapeutics, Inc.","issuer_ticker":"BLPH","issuer_name_source":null,"issuer_url":"/issuer/0001277994","owner_cik":null,"owner_name":"VHCP Management II, LLC; VEF Management IV, LLC; VHCP Co-Investment Holdings II, LLC; Venrock Healthcare Capital Partners II, L.P.; Venrock Partners Management, LLC; Koh Bong Y; VENROCK ENTREPRENEURS FUND IV L P; Venrock Partners, L.P.; VENROCK ASSOCIATES IV L P; Venrock Management IV, LLC","owner_display_name":"VHCP Management II, LLC","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":10,"other_reporting_owners":9,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":272000.0,"shares_display":"272,000","price_per_share":0.6467,"price_display":"0.65","price_state":"stated","total_value":175902.4,"total_display":"175,902.40","total_whole":"175,902","shares_owned_after":6474770.0,"shares_owned_after_display":"6,474,770","ownership_form":"I","is_10b5_1":null,"transaction_date":"2018-08-15","filed_date":"2018-08-16","scope":"insider"},{"id":6523511,"accession":"0001209191-18-047212","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-18-047212","line_url":"/filing/0001209191-18-047212#line-1","is_derivative":false,"issuer_cik":"0001277994","issuer_name":"Bellerophon Therapeutics, Inc.","issuer_ticker":"BLPH","issuer_name_source":null,"issuer_url":"/issuer/0001277994","owner_cik":null,"owner_name":"VHCP Management II, LLC; VEF Management IV, LLC; VHCP Co-Investment Holdings II, LLC; Venrock Healthcare Capital Partners II, L.P.; Venrock Partners Management, LLC; Koh Bong Y; VENROCK ENTREPRENEURS FUND IV L P; Venrock Partners, L.P.; VENROCK ASSOCIATES IV L P; Venrock Management IV, LLC","owner_display_name":"VHCP Management II, LLC","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":10,"other_reporting_owners":9,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":190977.0,"shares_display":"190,977","price_per_share":0.6486,"price_display":"0.65","price_state":"stated","total_value":123867.6822,"total_display":"123,867.68","total_whole":"123,868","shares_owned_after":6202770.0,"shares_owned_after_display":"6,202,770","ownership_form":"I","is_10b5_1":null,"transaction_date":"2018-08-14","filed_date":"2018-08-16","scope":"insider"},{"id":5422711,"accession":"0001277997-13-000004","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001277997-13-000004","line_url":"/filing/0001277997-13-000004#line-1","is_derivative":false,"issuer_cik":"0001239242","issuer_name":"Anacor Pharmaceuticals, Inc.","issuer_ticker":"ANAC","issuer_name_source":null,"issuer_url":"/issuer/0001239242","owner_cik":null,"owner_name":"Venrock Partners Management, LLC; VENROCK ASSOCIATES IV L P; ROBERTS BRYAN E; Venrock Partners, L.P.; VEF Management IV, LLC; VENROCK ENTREPRENEURS FUND IV L P; Venrock Management IV, LLC; VHCP Co-Investment Holdings, LLC; VENROCK HEALTHCARE CAPITAL PARTNERS LP; VHCP Management, LLC","owner_display_name":"Venrock Partners Management, LLC","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":10,"other_reporting_owners":9,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":150000.0,"shares_display":"150,000","price_per_share":14.06,"price_display":"14.06","price_state":"stated","total_value":2109000.0,"total_display":"2,109,000.00","total_whole":"2,109,000","shares_owned_after":3575535.0,"shares_owned_after_display":"3,575,535","ownership_form":"I","is_10b5_1":null,"transaction_date":"2013-11-15","filed_date":"2013-11-19","scope":"insider"},{"id":2981451,"accession":"0001277997-12-000004","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001277997-12-000004","line_url":"/filing/0001277997-12-000004#line-1","is_derivative":false,"issuer_cik":"0001277994","issuer_name":"Anacor Pharmaceuticals Inc","issuer_ticker":"ANAC","issuer_name_source":null,"issuer_url":"/issuer/0001277994","owner_cik":null,"owner_name":"VENROCK ASSOCIATES IV L P; VENROCK HEALTHCARE CAPITAL PARTNERS LP; VHCP Management, LLC; Venrock Partners, L.P.; Venrock Management IV, LLC; VENROCK ENTREPRENEURS FUND IV L P; VHCP Co-Investment Holdings, LLC; VEF Management IV, LLC; Venrock Partners Management, LLC","owner_display_name":"VENROCK ASSOCIATES IV L P","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":9,"other_reporting_owners":8,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":19273.0,"shares_display":"19,273","price_per_share":6.3019,"price_display":"6.30","price_state":"stated","total_value":121456.5187,"total_display":"121,456.52","total_whole":"121,457","shares_owned_after":3725535.0,"shares_owned_after_display":"3,725,535","ownership_form":"I","is_10b5_1":null,"transaction_date":"2012-09-20","filed_date":"2012-09-24","scope":"insider"},{"id":2354014,"accession":"0001277997-12-000003","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001277997-12-000003","line_url":"/filing/0001277997-12-000003#line-1","is_derivative":false,"issuer_cik":"0001277994","issuer_name":"Anacor Pharmaceuticals Inc","issuer_ticker":"ANAC","issuer_name_source":null,"issuer_url":"/issuer/0001277994","owner_cik":null,"owner_name":"Venrock Partners Management, LLC; VENROCK ASSOCIATES IV L P; VEF Management IV, LLC; Venrock Management IV, LLC; VHCP Co-Investment Holdings, LLC; VENROCK HEALTHCARE CAPITAL PARTNERS LP; VHCP Management, LLC; VENROCK ENTREPRENEURS FUND IV L P; Venrock Partners, L.P.","owner_display_name":"Venrock Partners Management, LLC","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":9,"other_reporting_owners":8,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":35000.0,"shares_display":"35,000","price_per_share":6.5087,"price_display":"6.51","price_state":"stated","total_value":227804.5,"total_display":"227,804.50","total_whole":"227,805","shares_owned_after":3744808.0,"shares_owned_after_display":"3,744,808","ownership_form":"I","is_10b5_1":null,"transaction_date":"2012-09-14","filed_date":"2012-09-18","scope":"insider"},{"id":3443881,"accession":"0001277997-12-000002","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001277997-12-000002","line_url":"/filing/0001277997-12-000002#line-2","is_derivative":false,"issuer_cik":"0001277994","issuer_name":"Anacor Pharmaceuticals Inc","issuer_ticker":"ANAC","issuer_name_source":null,"issuer_url":"/issuer/0001277994","owner_cik":null,"owner_name":"VEF Management IV, LLC; VHCP Co-Investment Holdings, LLC; VENROCK HEALTHCARE CAPITAL PARTNERS LP; VHCP Management, LLC; VENROCK ENTREPRENEURS FUND IV L P; Venrock Partners Management, LLC; Venrock Partners, L.P.; VENROCK ASSOCIATES IV L P; Venrock Management IV, LLC","owner_display_name":"VEF Management IV, LLC","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":9,"other_reporting_owners":8,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":15000.0,"shares_display":"15,000","price_per_share":6.5553,"price_display":"6.56","price_state":"stated","total_value":98329.5,"total_display":"98,329.50","total_whole":"98,330","shares_owned_after":3779808.0,"shares_owned_after_display":"3,779,808","ownership_form":"I","is_10b5_1":null,"transaction_date":"2012-09-13","filed_date":"2012-09-13","scope":"insider"},{"id":3443880,"accession":"0001277997-12-000002","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001277997-12-000002","line_url":"/filing/0001277997-12-000002#line-1","is_derivative":false,"issuer_cik":"0001277994","issuer_name":"Anacor Pharmaceuticals Inc","issuer_ticker":"ANAC","issuer_name_source":null,"issuer_url":"/issuer/0001277994","owner_cik":null,"owner_name":"VEF Management IV, LLC; VHCP Co-Investment Holdings, LLC; VENROCK HEALTHCARE CAPITAL PARTNERS LP; VHCP Management, LLC; VENROCK ENTREPRENEURS FUND IV L P; Venrock Partners Management, LLC; Venrock Partners, L.P.; VENROCK ASSOCIATES IV L P; Venrock Management IV, LLC","owner_display_name":"VEF Management IV, LLC","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":9,"other_reporting_owners":8,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":10177.0,"shares_display":"10,177","price_per_share":6.6427,"price_display":"6.64","price_state":"stated","total_value":67602.7579,"total_display":"67,602.76","total_whole":"67,603","shares_owned_after":3794808.0,"shares_owned_after_display":"3,794,808","ownership_form":"I","is_10b5_1":null,"transaction_date":"2012-09-11","filed_date":"2012-09-13","scope":"insider"},{"id":7517579,"accession":"0001277997-10-000005","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001277997-10-000005","line_url":"/filing/0001277997-10-000005#line-4","is_derivative":false,"issuer_cik":"0001277994","issuer_name":"Anacor Pharmaceuticals Inc","issuer_ticker":"ANAC","issuer_name_source":null,"issuer_url":"/issuer/0001277994","owner_cik":null,"owner_name":"Venrock Management IV, LLC; Venrock Partners Management, LLC; VENROCK ASSOCIATES IV L P; VENROCK ENTREPRENEURS FUND IV L P; VEF Management IV, LLC; Venrock Partners, L.P.","owner_display_name":"Venrock Management IV, LLC","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":6,"other_reporting_owners":5,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":600000.0,"shares_display":"600,000","price_per_share":5.0,"price_display":"5.00","price_state":"stated","total_value":3000000.0,"total_display":"3,000,000.00","total_whole":"3,000,000","shares_owned_after":2625535.0,"shares_owned_after_display":"2,625,535","ownership_form":"I","is_10b5_1":null,"transaction_date":"2010-11-30","filed_date":"2010-12-02","scope":"insider"},{"id":7594480,"accession":"0001277997-10-000003","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001277997-10-000003","line_url":"/filing/0001277997-10-000003#line-4","is_derivative":false,"issuer_cik":"0001267602","issuer_name":"ALIMERA SCIENCES INC","issuer_ticker":"ALIM","issuer_name_source":null,"issuer_url":"/issuer/0001267602","owner_cik":null,"owner_name":"VENROCK ENTREPRENEURS FUND IV L P; Venrock Partners, L.P.; Venrock Partners Management, LLC; VEF Management IV, LLC; Venrock Management IV, LLC; VENROCK ASSOCIATES IV L P","owner_display_name":"VENROCK ENTREPRENEURS FUND IV L P","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":6,"other_reporting_owners":5,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":306071.0,"shares_display":"306,071","price_per_share":11.0,"price_display":"11.00","price_state":"stated","total_value":3366781.0,"total_display":"3,366,781.00","total_whole":"3,366,781","shares_owned_after":3949070.0,"shares_owned_after_display":"3,949,070","ownership_form":"I","is_10b5_1":null,"transaction_date":"2010-04-27","filed_date":"2010-04-28","scope":"insider"},{"id":3569100,"accession":"0001305240-06-000002","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001305240-06-000002","line_url":"/filing/0001305240-06-000002#line-2","is_derivative":false,"issuer_cik":"0001298521","issuer_name":"Trubion Pharmaceuticals, Inc","issuer_ticker":"TRBN","issuer_name_source":null,"issuer_url":"/issuer/0001298521","owner_cik":"0001305240","owner_name":"Venrock Partners Management, LLC","owner_display_name":"Venrock Partners Management, LLC","owner_url":"/insider/0001305240","role":"Ten percent owner","role_mark":"%","role_mark_label":"Ten percent owner","role_mark_generic":"Ten percent owner","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":5840.0,"shares_display":"5,840","price_per_share":13.0,"price_display":"13.00","price_state":"stated","total_value":75920.0,"total_display":"75,920.00","total_whole":"75,920","shares_owned_after":308367.0,"shares_owned_after_display":"308,367","ownership_form":"I","is_10b5_1":null,"transaction_date":"2006-10-23","filed_date":"2006-10-25","scope":"insider"}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":1,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":1,"open_market":true},{"code":"S","label":"Open-market sale","n":0,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":1},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001600132","name":"Bellerophon Therapeutics, Inc.","url":"/issuer/0001600132","role":"Ten percent owner","n_filings":6,"first_seen":"2018-08-16","last_seen":"2019-10-28"},{"type":"issuer","type_label":"ISSUER","cik":"0001411158","name":"Anacor Pharmaceuticals, Inc.","url":"/issuer/0001411158","role":"Ten percent owner","n_filings":5,"first_seen":"2010-12-02","last_seen":"2013-11-19"},{"type":"issuer","type_label":"ISSUER","cik":"0001267602","name":"ALIMERA SCIENCES INC","url":"/issuer/0001267602","role":"Ten percent owner","n_filings":1,"first_seen":"2010-04-28","last_seen":"2010-04-28"},{"type":"issuer","type_label":"ISSUER","cik":"0001298521","name":"Trubion Pharmaceuticals, Inc","url":"/issuer/0001298521","role":"Ten percent owner","n_filings":1,"first_seen":"2006-10-25","last_seen":"2006-10-25"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001305240","retrieved_at":"2026-08-22T18:25:57+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-21","last_ingest":"2026-08-22T05:23:40.159918+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}